Key result
High-dose irradiation and chemotherapy linked to cutaneous angiosarcoma 14 years later.
Case Report (n=1)
This case highlights the risk of developing cutaneous angiosarcoma as a second malignant neoplasm years after high-dose irradiation and multidrug chemotherapy for PNET.
May signal late cutaneous angiosarcoma after PNET chemoradiation; hypothesis-generating and leaves open broader risk assessment.
Second malignant neoplasms (SMN) in late childhood or young adulthood in individuals who have been successfully treated for an initial malignancy have emerged as a late effect of therapy in survivors of childhood cancer. Although radiation therapy is frequently implicated, chemotherapy with alkylating agents and antimetabolites has also been associated with SMN. Soft tissue sarcomas are among the most frequent primary malignancies complicated by a SMN and account for a majority of nonhematolymphoid SMN. We present the clinical and pathologic findings in a patient who had a peripheral neuroepithelioma (primitive neuroectodermal tumor, PNET) of the soft tissues diagnosed at 17 years of age, was treated with high-dose irradiation and multidrug chemotherapy, and developed an angiosarcoma 14 years later. This case represents an uncommon combination of mesenchymal malignancies in a young patient with an unusually favorable clinical course following the diagnosis of PNET.
No takes yet. Share an insight, caveat, or question.
Coffin et al. (1992) conducted a case report in Second malignant neoplasm (cutaneous angiosarcoma) after peripheral primitive neuroectodermal tumor (n=1). High-dose irradiation and multidrug chemotherapy was evaluated on Development of second malignant neoplasm (angiosarcoma). High-dose irradiation and multidrug chemotherapy for a peripheral primitive neuroectodermal tumor at age 17 was followed by the development of a cutaneous angiosarcoma 14 years later.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: